This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
With a growing understanding of the role of inflammation in CNS neurodegenerative disorders such as Alzheimer's disease (AD), neuroinflammatory disease has discovered distinct immune responses involving the adaptive and innate immune systems at different stages of disease. These responses could be used as therapeutic targets as well as driving disease processes. Immunotherapeutic techniques that have proven effective in Alzheimer's disease are increasingly being applied to other neurodegenerative diseases. The function of particular immune cell populations in the pathophysiology of neurodegenerative disorders has received more attention in recent years. Researchers in the discipline are working to understand the molecular pathways that underpin neurodegenerative diseases, which is one of the most important concerns of our era.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of